Villanueva, Jaden Adam .
HRN: 22-56-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2023
OXACILLIN 500MG (VIAL)
09/15/2023
09/21/2023
IV
185mg
Q6h
Furuncle
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes